Quick links

Secure file transfer protocol Register or renew user

Contact us

Trouble logging in? Forgot password? We can help!

philavax@phila.gov

215-685-6784

215-238-6944

To onboard a new entity or clinic:

Complete the online reporting agreement form

Or fill out the

Reporting agreement form

then email it to
vaxreporting​@phila.gov
or fax to the contact above.

Clinic onboarding list

Complete in addition to the reporting agreement form to onboard more than 2 clinics.

Need help? Review the FAQ

Reporting agreement FAQ

On behalf of patients

Patient update request

Looking for something else?

PhilaVax program information

Flat file reporting guide

More PhilaVax resources

2026-2027 COVID-19 Vaccine Update

05 Aug 2026 2026-2027 COVID-19 Vaccine Update

Posted at 11:00h in COVID-19, General

Moderna will be the only COVID-19 product available after Thursday, August 6, 2026. 

Here are the 2026-2027 COVID-19 product updates:

  • Moderna: Spikevax 2025-2026 vaccines will remain available for ordering until the 2026-2027 formulation is approved. This includes vaccines for children 6 months – 11 years (NDC: 80777-0113-80) and vaccines for those 12 years+ (NDC: 80777-0112-96).
  • Pfizer: Comirnaty 2025-2026 vaccines will be open for ordering until 1 p.m. on Thursday, August 6, 2026. This includes vaccines for children 5 – 11 years (NDC: 00069-2501-10) and vaccines for those 12 years+ (NDC: 00069-2528-10).
  • Sanofi: Novavax 2025-2026 vaccines are no longer available.

At this time, we do not have information about when 2026-2027 formulation COVID-19 vaccines will be available through the Vaccines for Children (VFC) program. We will share updates as we receive them.

Reach out to dphproviderhelp@phila.gov if you have any questions.